Avelumab First-Line (1L) Maintenance for Advanced Urothelial Carcinoma (Uc): Long-Term Follow-Up Results from the Javelin Bladder 100 Trial.

AuthID
 P-00W-E77
18
Author(s)
Park, SH
·
Voog, E
·
Caserta, C
·
Perez-Valderrama, B
·
Gurney, H
·
Loriot, Y
·
Sridhar, SS
·
Tsuchiya, N
·
Sternberg, CN
·
Bellmunt, J
·
Aragon-Ching, JB
·
Blake-Haskins, A
·
Laliberte, RJ
·
Wang, J
·
Costa, NM
·
Grivas, P
Document Type
Abstract
Year published
2022
Published
in JOURNAL OF CLINICAL ONCOLOGY, ISSN: 0732-183X
Volume: 40, Issue: 6
Indexing
Wos®
Google Scholar®
Publication Identifiers
Wos: WOS:000771008900494
Source Identifiers
ISSN: 0732-183X
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

footer slogan

Useful Links

Get Help

© 2025 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service